ArticleScience translational medicine2019
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.
Hong Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this paperpooled itcites it